Download PDF

Promotional product theaters provide time for presentation of new research findings on products, showcasing of product details, demonstrations and highlights of new products. These sessions are promotional and are not eligible for continuing education credits. Registration will be required for Physician Payment Sunshine Act reporting.

Thursday, April 30, 2:15-3:15 PM (CDT)

Treatment Approaches to Delay Time to Relapse in Adult Patients with Schizophrenia

Learning Objectives

  1. Consider the impact of repeated relapses on adult patients with schizophrenia
  2. Review how recent treatment guidance recommends LAI use in adults with schizophrenia
  3. Present data on Janssen Neuroscience treatments that:
    • Can be used for adults with schizophrenia in alignment with the new treatment guidance on LAIs
    • Can delay time to relapse in adults with schizophrenia


Sanjai Rao, MD
Associate Clinical Professor, Psychiatry, University of San Diego
Associate Training Director, VA Medical Center in San Diego
Site Director, VA Medical Center in San Diego

Supported by

Janssen Pharmaceuticals, Inc.